PRKN and neoplasm: As an independent approach, expression of E3 ligase-defective Parkin S65A or C431S mutant (Fig. S6A) failed to reduce tumor cell adhesion to fibronectin or fibrinogen (Fig. S6B) and did not affect single-cell motility (26), compared with WT Parkin.